1,319
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG–PCCL-modified magnetic iron oxide nanoparticles

, , , , , , , , , , , & show all
Pages 1284-1294 | Received 03 Aug 2017, Accepted 25 Aug 2017, Published online: 11 Sep 2017

References

  • Bossy-Wetzel E, Green DR. (2000). Detection of apoptosis by annexin V labeling. Meth Enzymol 322:15–8.
  • Cole AJ, David AE, Wang J, et al. (2011). Magnetic brain tumor targeting and biodistribution of longcirculating PEG-modified, cross-linked starch coated iron oxide nanoparticles. Biomaterials 32:6291–301.
  • Cole AJ, Yang VC, David AE. (2011). Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 29:323–32.
  • Danhier F, Lecouturier N, Vroman B, et al. (2009). Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 133:11–7.
  • Del Vecchio S, Zannetti A, Fonti R, et al. (2007). Nuclear imaging in cancer theranostics. Q J Nucl Med Mol Imaging 51:152–63.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. (2008). Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–95.
  • Dobrovolskaia MA, Clogston JD, Neun BW, et al. (2008). Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–7.
  • Elsaesser A, Howard CV. (2012). Toxicology of nanoparticles. Adv Drug Deliv Rev 64:129–37.
  • Gou M, Men K, Shi H, et al. (2011). Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3:1558–67.
  • Gregory CD, Pound JD. (2010). Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 15:1029–49.
  • Kuang Y, Yuan T, Zhang Z, et al. (2012). Application of Ferriferous oxide modified by chitosan in gene delivery. J Drug Deliv 2012:920764.
  • Larsen EK, Nielsen T, Wittenborn T, et al. (2009). Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumor. ACS Nano 3:1947–51.
  • Li C, Cui J, Wang C, et al. (2008). Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy. Eur J Pharm Biopharm 70:657–65.
  • Liu Y, Deng H, Xiao C, et al. (2014). Cytotoxicity of calcium rectorite micro/nanoparticles before and after organic modification. Chem Res Toxicol 27:1401–10.
  • Liu Y, Samsonova O, Sproat B, et al. (2011). Biophysical characterization ofhyper-branchedpolyethylenimine-graftpolycaprolactone-block-mono-methoxyl-poly (ethylene glycol) copolymers (hy-PEI-PCL-mPEG) for siRNA delivery. J Control Release 153:262–8.
  • Luo Z, Jin L, Xu L, et al. (2016). Thermosensitive PEG–PCL–PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium. Drug Deliv 23:63–8.
  • Moore A, Marecos E, Bogdanov A Jr, Weissleder R. (2000). Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–74.
  • Qiu JF, Gao X, Wang BL, et al. (2013). Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ɛ-caprolactone) micelles for the solubilization and in vivo delivery of luteolin. Int J Nanomed 8:3061–9.
  • Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed 8:2769–81.
  • Rogošić M, Mencer HJ, Gomzi Z. (1996). Polydispersity index and molecular weight distributions of polymers. Eur Polym J 32:1337–44.
  • Sun C, Du K, Fang C, et al. (2010). PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 4:2402–10.
  • van Heerde WL, de Groot PG, Reutelingsperger CP. (1995). The complexity of the phospholipid binding protein Annexin V. Thromb Haemost 73:172–9.
  • Wang J, Jia J, Liu J, et al. (2013). Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Drug Deliv 20:356–63.
  • Wang Z, Li M, Yu B, et al. (2012). Nanocalcium-deficient hydroxyapatite–poly (ɛ-caprolactone)–polyethylene glycol-poly (ɛ-caprolactone) composite scaffolds. Int J Nanomed 7:3123–31.
  • Xie J, Lee S, Chen X. (2010). Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62:1064–79.
  • Xu Y, Jin X, Ping Q, et al. (2010). A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. J Control Release 146:299–308.
  • Zhang W, Li C, Shen C, et al. (2016). Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Drug Deliv 23:2575–80.